Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Alessandro Di Costanzo"'
Autor:
Alessandro Borghese, Alessandro Di Costanzo, Michele Riccio, Luca Maresca, Giovanni Breglio, Andrea Irace
Publikováno v:
Energies, Vol 14, Iss 23, p 8055 (2021)
In this work, a comparison between the gate-driving requirements of p-GaN HEMTs with gate contact of Schottky and Ohmic type is presented. Furthermore, the presence of a gate current of different magnitude is experimentally verified for both types of
Externí odkaz:
https://doaj.org/article/f65870b83b354b7dbacab2daf2bc8ea4
Autor:
F. Arizio, Celeste Cagnazzo, Giuseppe Procopio, Oriana Nanni, Rosita Cenna, V. Franchina, Nicla La Verde, Stefania Gori, Vincenzo Adamo, Alessandro Di Costanzo, Fabrizio Nicolis, Angela Maria Elena Frazzetto
Publikováno v:
Expert Review of Pharmacoeconomics & Outcomes Research. 21:433-440
Background: New trends are emerging in clinical research, such as patient empowerment and an active role in influencing health and research ethics. Patients’ involvement is considered pivotal by st...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a25a95b75ff5d031d4880a011fddb94
https://doi.org/10.1080/14737167.2021.1850274
https://doi.org/10.1080/14737167.2021.1850274
Autor:
Lorenzo Codecasa, Alessandro Di Costanzo, Vincenzo d’Alessandro, Roseanne Duca, Donata Gualandris, Arianna Morelli, Francesca De Viti, Claudio Maria Villa
Publikováno v:
2021 27th International Workshop on Thermal Investigations of ICs and Systems (THERMINIC).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0014880d2ce4883bc229cf8600070c7d
https://doi.org/10.1109/therminic52472.2021.9626532
https://doi.org/10.1109/therminic52472.2021.9626532
Autor:
Francesco Di Costanzo, Luisa Di Cerbo, Francesca Castiglione, Elena Lastraioli, Alessandro Di Costanzo, Luca Messerini, Annarosa Arcangeli, Miriam Armenio, Lorenzo Antonuzzo, Daniele Lavacchi, Beatrice Fantechi
Publikováno v:
Oncology Letters
Patients with metastatic colorectal cancer (mCRC) are routinely screened for either K- and N-RAS to select the appropriate treatment. The present study aimed to evaluate the concordance between K- and NRAS status in the tissue (either primary tumor o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::396be4c9d5aa69cfb5b12e8a718ea50f
https://doi.org/10.3892/ol.2020.12276
https://doi.org/10.3892/ol.2020.12276
Autor:
F. Arizio, Francesca Vannini, Alessandro Di Costanzo, Rosita Cenna, Gianna Tabaro, Giuseppe Procopio, Veronica Franchina, Stefania Gori, Celeste Cagnazzo, Oriana Nanni
Publikováno v:
Tumori. 106(4)
Background: The Agenzia Italiana del Farmaco (AIFA) Determination 809/2015 sets all the requirements that clinical units and laboratories must meet in order to conduct phase I studies. Requirements include buildings, equipment, personnel, emergency m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9891090e1c0bfdcb3eb49a66c1411aff
https://pubmed.ncbi.nlm.nih.gov/31394978
https://pubmed.ncbi.nlm.nih.gov/31394978
Autor:
Antonio Russo, Giuseppe Toscano, Massimo Di Maio, Vincenzo Adamo, Celeste Cagnazzo, V. Franchina, Lorenzo Antonuzzo, Sara Delfanti, Stefania Cusenza, Margherita Tambaro, Stefania Gori, Alessandro Di Costanzo, Giuseppina Rosaria Rita Ricciardi, Tindara Franchina, Rosita Cenna, Oriana Nanni, F. Marchetti, Fabio Dascanio, Franca Fagioli, Patrizia Piccirillo
Publikováno v:
Journal of Clinical Oncology. 39:e24121-e24121
e24121 Background: Barriers for low recruitment in clinical trials have been classified based on three main sources: physician, patient, system. A primary role is played by a low patient awareness, which often leads to a lack of confidence in science
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06adbb0bcd54f4fd7a1bcf2575996b4f
https://doi.org/10.1200/jco.2021.39.15_suppl.e24121
https://doi.org/10.1200/jco.2021.39.15_suppl.e24121
Autor:
Laura Doni, Elisa Giommoni, Agnese Paderi, Lorenzo Antonuzzo, Serena Pillozzi, Alessandro Di Costanzo, Marinella Micol Mela, Roberta Giorgione, Elisa Pellegrini
Publikováno v:
Journal of Clinical Oncology. 39:345-345
345 Background: Nivolumab and ipilimumab are associated with immune-related adverse events (irAEs) and, to date, few biomarkers predictive of ICIs toxicity are reported in mRCC. Methods: We conducted a single-center, observational, retrospective stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a4b4b016ac54f8685d5bc23b44565ba
https://doi.org/10.1200/jco.2021.39.6_suppl.345
https://doi.org/10.1200/jco.2021.39.6_suppl.345
Autor:
Silvia Novello, Massimo Di Maio, Massimo Aglietta, Teresa Severina Di Stefano, Elisa Gobbini, F. Arizio, Roberta Matocci, Rita Chiari, P. Petrillo, Alessandro Di Costanzo, Valentina Polo, Isabella Sperduti, Sara Pilotto, Celeste Cagnazzo, Emilio Bria, Domenico Galetta, Giulia Pasello
Introduction Contract research organization (CRO) support is largely included in clinical trial management, although its effect in terms of time savings and benefit has not yet been quantified. We performed a retrospective multicenter analysis of lun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::984a32735396930c0c38828f2015f8b7
http://hdl.handle.net/11577/3367861
http://hdl.handle.net/11577/3367861
